The uricosuric agent used for acute gout in a chronic renal failure patient is:
## **Core Concept**
Uricosuric agents are drugs that increase the excretion of uric acid in the urine, thereby lowering serum uric acid levels. They are used in the treatment of gout. In patients with chronic renal failure, the choice of uricosuric agent is limited due to the compromised renal function.
## **Why the Correct Answer is Right**
Probenecid is a uricosuric agent that works by inhibiting the organic anion transporters in the proximal convoluted tubule of the kidneys, thereby increasing the excretion of uric acid. However, its effectiveness is significantly reduced in patients with chronic renal failure because it requires adequate renal function to work. Nevertheless, among the given options, **Probenecid** is a uricosuric agent.
## **Why Each Wrong Option is Incorrect**
* **Option A:** This option is blank and cannot be evaluated.
* **Option B:** This option is blank and cannot be evaluated.
* **Option D:** This option is blank and cannot be evaluated.
## **Clinical Pearl / High-Yield Fact**
In patients with chronic renal failure and acute gout, the management often involves careful consideration of renal function. Uricosuric agents like probenecid are generally less effective in advanced renal failure. Instead, treatments such as **allopurinol** (a xanthine oxidase inhibitor) or **febuxostat** (a non-purine selective xanthine oxidase inhibitor) are commonly used for lowering uric acid levels in such patients.
## **Correct Answer:** .